abbvie inc (4AB:Frankfurt)
Transactions by ABBVIE INC (4AB) in the last 6 months
AbbVie Inc. (NYSE:ABBV) signed a definitive agreement to acquire Pharmacyclics Inc. (NasdaqGS:PCYC) from ProQuest Investments and others for $19.9 billion in cash and stock on March 4, 2015. Under the terms of the agreement, AbbVie will acquire all of the outstanding shares of Pharmacyclics through a tender offer, followed by a second-step merger. In the tender offer, AbbVie will acquire all of the outstanding shares of Pharmacyclics' common stock for $261.25 per share, ...
J.P. Morgan Securities LLC
AbbVie Inc. (NYSE:ABBV) acquired manufacturing site in Tuas Biomedical Park on November 20, 2014.
|Abbott Laboratories||$48.32 USD||-0.14|
|Amgen Inc||$167.91 USD||-1.26|
|Bristol-Myers Squibb Co||$65.80 USD||-0.20|
|Eli Lilly & Co||$71.58 USD||-0.82|
|Medtronic PLC||$77.61 USD||-0.89|
|View Industry Companies|